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Certain strains of Staphylococcus aureus usually belonging to phage group II produce epidermolytic toxins (ETA and ETB) which cause intra- 
epidermal splitting in mice, neonates and occasionally adults. Amino acid sequences of ETA and ETB have been reported but the mechanism of 
epidermolysis remains unknown. A search of the NBRF-PIR computer database showed the toxins to have significant sequence similarity with 
staphylococcal V8 protease and that the catalytic triad of V8 protease is present in ETA and ETB. Comparison of ETA, ETB and V8 protease 
with other members of the trypsin-like serine protease family revealed little homology save for the immediate vicinity of the residues constituting 
the catalytic triad. The toxins, therefore, exhibit a distant relationship to mammalian serine proteases. A potential Caz+-binding loop was identified 
in ETA (but not ETB) on the basis of sequence similarity with the second calcium-binding loop of rat intestinal calcium-binding protein. Epider- 
molysis produced by ETA in the mouse bioassay was shown to be inhibited by the presence of EDTA consistent with a Caz+-dependent mechanism. 
Epidermolytic toxin; Staphylococcus aureus; Serine protease 
1. INTRODUCTION 
The clinical term for the condition induced by epider- 
molytic toxins (ET) is the Staphylococcal Scalded Skin 
Syndrome (SSSS) whereby fluid-filled blisters form, 
coalesce, and rapidly rupture leaving confluent patches 
of reddened skin resembling a first degree burn [1,2]. 
Staphylococci, colonising the nose or umbilical stump, 
produce ET which are absorbed and circulate 
systemically [3]. Clinical isolates may be screened for 
the production of toxin by an in vivo mouse bioassay 
t41. 
duced), dissolution of the desmosomal plaque occurs, 
which can be inhibited by neutral serine protease in- 
hibitors [lo]. 
Outbreaks occur in maternity units as newborn 
babies are particularly susceptible to the toxins [5]. The 
toxins reach the epidermis by diffusing from dermal 
capillaries and separation occurs in the stratum 
granulosum [6]. Histological appearance and site of ac- 
tion distinguish SSSS from other causes of blistering [7] 
but the mechanism of epidermolysis is unknown 
although it is assumed that intercellular cohesive 
forces, mostly generated by desmosomes, are 
disrupted. Beneath and attached to the desmosome lies 
a condensation of filaments which help maintain the 
cytoskeleton by forming a framework within the cell. 
The toxins bind to the filaggrin group of proteins [8] 
which support these filaments [9], and are therefore in- 
directly associated with the desmosome. In cantharide 
acantholysis (whereby intraepidermal blisters are pro- 
Original theories on the action of ET included 
possibilities that disappearance of intercellular vesicles 
heralded the release of a proteolytic enzyme which 
caused desmosomal disruption [6], or that the toxins 
themselves acted as trypsin-like enzymes [ 111. 
However, addition of protease inhibitors to both in 
vitro and in vivo models of epidermolysis failed to in- 
hibit epidermal splitting [12- 151, and until now it was 
generally agreed that the toxins have no proteolytic ac- 
tivity [ 15,161. This paper reports the finding of se- 
quence similarity between the epidermolytic toxins and 
staphylococcal V8 protease and the subsequent attempt 
to link observed structural characteristics with 
biological function. 
2. MATERIALS AND METHODS 
2.1. Databank search 
As the primary structures of the two toxins [17-191 share 40% se- 
quence identity, it was decided to look for homology with proteins of 
known function. This was done by rapid scanning of the National 
Biomedical Research Foundation - Protein Identification Resource 
(NBRF-PIR) databank (version 20) using the program FASTP [20] 
with a k-tuple parameter of 1. Fig. 1 shows the final sequence align- 
ment achieved with the program MULTALIGN [21] and small 
manual adjustments. 
2.2. Preparation of toxin 
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typed Group II (3A, 3C) and was partialty purified from a single co& 
ony inoculum by ammonium sulphate fractionation and ion- 
exchange chromatography [22]. 2 mg partially purified toxin product 
tested positive within 60 min in the in vivo mouse bioassay. 
2.3. Bioassay 
Bioassay was carried out by subcutaneous injection into the epider- 
mis of 18-day-old hairless mice 14,231. A positive Nikolsky sign 
(wrinkIing or peeling of the skin) appearing lo-120 min later 
signified the presence of ET. A negative control was provided by S. 
aureus strain NCTC 8325 (i09 cfu in 0.2 ml nutrient broth). In- 
hibitors di-isopropylfluorophosphate (DFP) (10~1 of 50 mM DFP in 
isopropanol), phenylmethanesulphonytfluoride (PMSF) (30 pl of 
2 m&ml PMSF in isopropanol) and chelating agent ethylenediamine- 
tetraacetic acid (EDTA) (0.2 ml of 50 mM EDTA, pH 7.5) were add- 
ed to solutions of toxin (2 mg partially purified toxin in 0.2 ml Tris 
50 mM, pH 7.5) in an attempt o inhibit epidermdysis. Staphylococ- 
cal V8 protease (250 IU in 0.2 ml of Tris 50 mM, pH 7.5) was also 
inoculated into mice in a similar attempt o inhibit its effect on skin 
by adding DFP (lop1 of 50 mM DFP in isopropanol). 
Inhibitors were added to toxin and V8 protease solutions 12 h 
before inoculation and allowed to stand at room temperature until in- 
jected. The mice originated from one litter, and the experiment 
repeated with different litters over a period of 3 months. Failure to 
observe epidermoiysis within 240 min was regarded as a negative 
rest&, and the experiment erminated. 
3. RESULTS AND DISCUSSION 
The computer search revealed 25 % sequence identity 
of both toxins to the sequence of V8 serine protease 
also from Staphylococcus aureus. Significant scores 
[21] for the alignment (after removal of the C-terminal 
tail of V8 protease, residues 217-268) were 11.4 and 
10.6 standard deviations from the mean for ETA and 
ETB, respectively, after 100 sequence randomisations. 
V8 protease is a member of the trypsin-like serine pro- 
tease family unusual in its specificity for cleavage on 
the C-terminal side of acidic amino acid residues and in 
possessing no disulphide bridges [24]. 
The residues of the catalytic triad, NisJf , Asp-93 
and Ser-169 (V8 protease numbering) are present in 
both toxins and are located in three of the regions 
showing the highest sequence conservation. The region 
of greatest sequence identity surrounds the catalytic 
serine and includes Gly-167 and Gly-170, which occupy 
regions of (@, w) space disallowed to residues possessing 
side chains in the 3-dimensional structures of known 
20 40 * 
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220 240 260 
V8 . . . . EDIHFANDDQYNNPDNPDNPNNPDNPNNPDEPNNPDNPNNPDNPDNGDNNNSDNPDAA 
ETa . . . INEKNE 
ETb . . . NTFGDTLGHDLKKRAKLDK 
Fig. 1. Sequence aIignment of ETA and ETB with the staphylococcal V8 serine protease. Many conservative substitutions are observed throughout 
the length of the molecules. identical residues in all three sequences are boxed. Three highly conserved regions in the two toxin sequences are 
indicated by horizontal bars. Residues comprising the cataiytic triad are indicated by an asterisk and the alignment with bovine ~~yrno~~sin 
(Chy) and Stre~fo~~ces griseus trypsin (SGT) shown in the vicinity of these residues. Sequence similarity was identified using the NBRF-PIR 
protein sequence data bank using the program FASTP. 
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proteases. The catalytic triad of residues lies within or 
close to three regions originally identified as showing 
strong conservation between the two toxins (solid bars 
in Fig. 1) [17,18]. It is now possible to rationalise the 
existence of these conserved regions in terms of preser- 
vation of the protease active site. Little sequence 
similarity is observed to the sequences of mammalian 
serine proteases such as chymotrypsin or to other 
bacterial proteases such as Streptomyces griseus tryp- 
sin, save for the immediate vicinities of the catalytic 
residues (Fig. 1). However, this is sufficient to suggest 
a common evolutionary origin and it was concluded 
that ETA and ETB could be serine proteases. 
Previous work has confirmed that the biological ac- 
tion of ETA, but not ETB, is dependent upon the 
presence of Ca2+ ions 125,261. We therefore studied the 
structures of ETA and ETB in order to identify a possi- 
ble calcium binding site present in ETA but not ETB. 
Scanning the sequence database revealed in the top 50 
hits that residues 93-107 in ETA (residues 73-87 in 
Fig. 1) showed similarity with a region of rat in- 
testinal/placental Ca2+-binding protein (ICB) which 
contains its second EF-hand Ca2+-binding loop [27,28] 
(see Fig. 2). All of the calcium ligating positions which 
are normally coordinated through side chain oxygens in 
EF-hand motifs [29] are similarly occupied by oxygen- 
bearing side chains of appropriate length in ETA, the 
only exception being position 9 which is frequently 
replaced by a water molecule [28]. Threonine at posi- 
tion 6 in ETA replaces glycine observed in the majority 
of such motifs [28,30], but variation can occur at this 
position, e.g. the first EF-hand loop of ICB (glycine 
replaced by proline and asparagine). In such a case, 
glycine at position 4, also seen in ETA, is considered 
obligatory [28] in order for the loop to bind calcium. 
The ETB sequence fulfills less criteria for an EF-hand 
motif and is not likely to bind Ca’+. 
The three-dimensional structure of trypsin-like serine 
proteases is based on two domains each containing a @- 
barrel usually of six strands and little a-helical content. 
The ETA Ca2+-binding loop is probably not flanked by 
a-helices as in the classical EF-hand, but by P-strands 
or P-turns as recently observed in galactose-binding 
protein [30]. 
Incubation of toxin with serine protease inhibitors 
DFP and PMSF prior to subcutaneous inoculation in 
mice failed to inhibit epidermal splitting, but the time 
taken for epidermolysis to occur was prolonged when 
an inhibitor was present (Table I). Larger doses of 
DFP/PMSF, which may have produced total inhibi- 
tion, caused toxic effects in the mice and death occur- 
red before a positive/negative result could be obtained. 
Complete inhibition was obtained using 
ethylenediaminetetracetic a id (EDTA) and this effect 
was reversed with the addition of calcium chloride. The 
epidemic strain of S. aureus from a hospital outbreak 
thus produces ETA. Inoculation of VS protease into 
1234567 8 9 10 11 12 
* . t + a 
ICB 57 DKDGDGE "SY E E FEV 71 
ETA 93 DDNGNTE TPY G E Y E Y 107 
ETB 86 DAEKNEFPTPY 0 K F E A 101 
Fig. 2. Sequence similarity of residues 57-71 of the rat 
intestinal/placental Ca2+-binding protein (ICB) to a region of ETA 
as identified by scanning the NBRF-PIR databank using the program 
FASTP. Positions 1-12 constitute the Ca*+-binding loop and the 
symbols indicate Ca*+-binding residues. *, indicates a monodentate 
side chain ligand. + , indicates coordination through a main chain 
carbonyl. # , indicates coordination through a side chain oxygen or 
frequently a water molecule. -, indicates generally bidentate 
coordination through a glutamate side chain. A shorter or uncharged 
side chain at this position is unable to coordinate Ca*+ through two 
oxygen molecules. The sequence for ETB is given for comparison. It 
is unlikely to bind calcium due to a longer side chain at position 3 and 
the absence of glutamic acid at position 12. The loop in ETB also 
includes an insertion after position 7. 
mouse skin caused a non-specific breakdown of the 
epidermis which was completely inhibited by DFP. 
In conclusion, we suggest hat the epidermolytic tox- 
ins are members of the trypsin-like serine protease 
Table I 
The table shows the effect of protease inhibitors DFP, PMSF and 
chelating agent EDTA on the time taken in minutes for epidermolysis 
to occur using the in vivo mouse bioassay following subcutaneous 
inoculation with partially purified toxin [4]. Also included is the time 
taken for skin reaction to occur following inoculation with V8 
protease and the effect produced by adding DFP 
Epidermolysis 
Control Toxinb 
NCTC 8325” (2 mg) 
Non-specific 
skin 
reaction 
V8 proteaseC 
(250 IU) 
Test > 240 60 100 
DFP 
10 ,J of 50 mM DFP 
in isopropanol not tested 120 > 240 
PMSF 
30 ~1 of 2 mg.ml-’ 150 
PMSF in isopro- (poor posi- 
pan01 not tested tive) not tested 
EDTA 
0.2 ml of 50 mM 
EDTA pH 7.5 not tested > 240 not tested 
EDTA/Ca*+ 
0.2 ml of 50 mM 
EDTA + 50 mM 
CaC12, pH 7.5 not tested 65 not tested 
* Non-toxin producing Staphylococcus aureus (lo9 cfu in 0.2 ml 
nutrient broth) 
b Partially purified toxin (2 mg in 0.2 ml Tris buffer (50 mM) pH 
7.5) from epidemic strain isolated during hospital outbreak [5] 
’ 250 IU V8 protease in 0.2 ml of Tris buffer (50 mM) pH 7.5 
NO skin reaction occurred following subcutaneous inoculation with 
the following: 0.2 ml of EDTA 50 mM/CaCb 50 mM, pH 7.5; 
0.2 ml of Tris 50 mM, pH 7.5 + each of 40 pl isopropanol/5 ~1 of 
50 mM DFP in isopropanoY5 ,ul of 1 mg.ml-’ PMSF in isopropanol 
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family, and together with V8 protease represent some 
of the most distinct relations to mammalian enzymes o 
far identified. They possess all the catalytic apparatus 
necessary for protease activity. We therefore propose 
that the toxins exert a proteolytic effect which is 
ultimately responsible for the disruption of the cohesive 
elements necessary for cell adhesion, although as yet, 
knowledge of the natural substrate is unavailable. 
These results also have implications for the 
physiologi~ai mechanisms involved in cellular adhesion 
and are therefore relevant to dermatologicat studies on 
other blistering diseases. 
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